编号 | 时间 | 题目 | 讲者 | 单位 |
---|---|---|---|---|
1 | 16:00-16:10 |
Welcome and Introduction
Markus Peck
University of Vienna
|
||
2 | 16:10-16:40 |
Clinical utility of new HBV biomarkers |
Henry Lik Yuen Chan | Union Hospital of Hong Kong |
3 | 16:40-17:00 |
Epidemiology and Outcomes of Non-viral HCC |
Mindie Nguyen | Stanford |
4 | 17:00-17:20 |
Optimal Management in the Era of Evolution of the Treatment for HCC |
Kwang-Hyub HAN | Yonsei University College of Medicine |
5 | 17:20-17:40 |
Progress in Clinical Trials of Novel Drugs for Hepatitis B |
Jidong Jia | Beijing Friendship Hospital Capital Medical University |
6 | 17:40-18:00 |
Risk Factors of HCC in HBV Patients – Implications for Therapy and Surveillance |
Jian SUN | Nanfang Hospital, Southern Medical University |
7 | 18:00-18:20 |
New Evidence on Systemic Treatment of HCC |
Markus Peck | University of Vienna |
8 | 18:20-18:30 |
Discussion
Markus Peck
University of Vienna /
Henry Lik Yuen Chan
Union Hospital of Hong Kong /
Mindie Nguyen
Stanford /
Kwang-Hyub HAN
Yonsei University College of Medicine /
Jidong Jia
Beijing Friendship Hospital Capital Medical University /
Jian SUN
Nanfang Hospital, Southern Medical University
|